Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-20-010603
Filing Date
2020-05-13
Accepted
2020-05-13 16:49:11
Documents
62
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q kmph20200331_10q.htm 10-Q 1568826
2 EXHIBIT 31.1 ex_175664.htm EX-31.1 14660
3 EXHIBIT 31.2 ex_175665.htm EX-31.2 14743
4 EXHIBIT 32.1 ex_175666.htm EX-32.1 7197
5 EXHIBIT 32.2 ex_175667.htm EX-32.2 7457
  Complete submission text file 0001437749-20-010603.txt   6090790

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT kmph-20200331.xml EX-101.INS 1089637
7 XBRL TAXONOMY EXTENSION SCHEMA kmph-20200331.xsd EX-101.SCH 63317
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kmph-20200331_cal.xml EX-101.CAL 31951
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kmph-20200331_def.xml EX-101.DEF 423969
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE kmph-20200331_lab.xml EX-101.LAB 350184
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kmph-20200331_pre.xml EX-101.PRE 443686
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

EIN.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36913 | Film No.: 20873791
SIC: 2834 Pharmaceutical Preparations